Evaluation of Some Biochemical Markers of Bone Turnover in Childern and Adolescents With Type 1 Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-10

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Type 1 diabetes is associated with many longterm complications as retinopathy,neuropathy and nephropathy. Recently, several studies have linked type 1 diabetes to bone fragility.Studies conducted on patients with type 1 diabetes have concluded that bone is negatively affected in type 1 diabetes with impaired bone density,increased fracture risk and impaired bone turnover markers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

NCT04289727

Type1diabetes

COMPLETED

Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

NCT01592539

Type 1 Diabetes, Bone

COMPLETED

Skeletal Muscle Health in Children With Type 1 Diabetes

NCT04288063

Type 1 Diabetes

COMPLETED

Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes

NCT03751839

Type 1 Diabetes Mellitus

COMPLETED NA

the Type ONe dIabetic Bone Collaboration Study

NCT05673837

Osteoporosis Secondary Diabetes Mellitus, Type 1

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cases group

childern and adolescents with type 1 diabetes

serum ostecalcin,serum sclerostin and parathroid profile

Intervention Type DIAGNOSTIC_TEST

evaluation of bone turnover markers in blood

control group

age and sex matched control childern and adolsecents

serum ostecalcin,serum sclerostin and parathroid profile

Intervention Type DIAGNOSTIC_TEST

evaluation of bone turnover markers in blood

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

serum ostecalcin,serum sclerostin and parathroid profile

evaluation of bone turnover markers in blood

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* childern and adolsecents below 16 years of age diagnsed with type 1 diabetes for at least 1 year age and sex-matched control childern and adolsecents will be included